Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference

    NEXT STORY
    RedHill Biopharma Announces New European and Japanese Patents for Talicia®
    PREV STORY
    Axsome Therapeutics Initiates MOMENTUM Phase 3 Trial of AXS-07 in Migraine
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Trinity Biotech Announces Results for Q1, 2020

    author_avatar
    NASDAQ Market News

    Immunomedics to Present at Cowen and Company 36th Annual Health Care Conference

    MORRIS PLAINS, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced ...

    author_avatar
    NASDAQ Market News

    IVD Global Markets to Add $28 Billion Over 5 Years

    WELLESLEY, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Technological advancements, the aging populations of ...

    author_avatar
    NASDAQ Market News